Impact of prior HAART use on clinical outcomes in a large Kenyan HIV Treatment Program

Current HIV Research

Volumn 7, Issue 4, 2009, Pages 441-446

  Chung, Michael H ^a   Drake, Alison L ^a   Richardson, Barbra A ^a,b   Reddy, Ashok ^a   Thiga, Joan ^c   Sakr, Samah R ^c   Kiarie, James N ^d   Yowakim, Paul ^c   John Stewart, Grace C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c Internal Medicine and Critical care Department   (Kenya)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Africa; Clinic flow; Experience; HAART; HIV 1; Mortality

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EDUCATIONAL STATUS; FOLLOW UP; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; KENYA; MAJOR CLINICAL STUDY; MARRIAGE; MORTALITY; PATIENT CARE; SURVIVAL RATE; TREATMENT OUTCOME; WEIGHT CHANGE; AFRICA; BODY WEIGHT; FEMALE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PATHOLOGY;

ADULT; AFRICA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; KENYA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 69849086171     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788680552     Document Type: Article

References (17)

1. Katabira ET, Oelrichs RB. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges. AIDS 2007; 21 (Suppl 4): S5-10.
2. Fairall LR, Bachmann MO, Louwagie GM, et al. Effectiveness of antiretroviral treatment in a South African program: a cohort study. Arch Intern Med 2008; 168: 86-93.
3. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005; 353: 2325-2334 (Pubitemid 41713744)
4. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296: 782-793 (Pubitemid 44223102)
5. Wools-Kaloustian K, Kimaiyo S, Diero L, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub- Saharan Africa: experience from western Kenya. AIDS 2006; 20: 41-48 (Pubitemid 41818113)
6. Wagner G, Ryan G, Taylor S. Formative evaluation of antiretroviral therapy scale-up efficiency in sub-Saharan Africa. AIDS Patient Care STDS 2007; 21: 871-888
7. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. J Acquir Immune Defic Syndr 2008; 47: 101-107 (Pubitemid 351619376)
8. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18: 887-895 (Pubitemid 38553709)
9. Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 2005; 41: 217-224 (Pubitemid 40962502)
10. Sow PS, Otieno LF, Bissagnene E, et al. Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries. J Acquir Immune Defic Syndr 2007; 44: 262-267 (Pubitemid 46328341)
11. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817-824
12. Etard JF, Ndiaye I, Thierry-Mieg M, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006; 20: 1181-1189 (Pubitemid 43786107)
13. Marazzi MC, Liotta G, Germano P, et al. Excessive Early Mortality in the First Year of Treatment in HIV Type 1-Infected Patients Initiating Antiretroviral Therapy in Resource-Limited Settings. AIDS Res Hum Retroviruses 2008; 24(4): 555-560 (Pubitemid 351571039)
14. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005; 19: 2141-2148 (Pubitemid 41669003)
15. Lawn SD, Myer L, Harling G, et al. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 2006; 43: 770-776 (Pubitemid 44330743)
16. Groves T, Wagner EH. High quality care for people with chronic diseases. BMJ 2005; 330: 609-610 (Pubitemid 40444751)
17. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998; 1: 2-4.